{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:35:22Z","timestamp":1793392522959,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002330","name":"Nova Scotia Department of Health and Wellness","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002330","name":"Nova Scotia Department of Health and Wellness","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12888-018-1746-3","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T21:41:38Z","timestamp":1528926098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Patient care activities by community pharmacists in a capitation funding model mental health and addictions program"],"prefix":"10.1186","volume":"18","author":[{"given":"Andrea L.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,14]]},"reference":[{"key":"1746_CR1","volume-title":"Focus on mental health: the contribution of the pharmacist","author":"International Pharmaceutical Federation (FIP)","year":"2015","unstructured":"International Pharmaceutical Federation (FIP). Focus on mental health: the contribution of the pharmacist. 2015. \n                    http:\/\/www.fip.org\/files\/Focus_on_mental_health_-final.pdf\n                    \n                  . Accessed 11 July 2016."},{"key":"1746_CR2","doi-asserted-by":"publisher","first-page":"10967","DOI":"10.3390\/ijerph111010967","volume":"11","author":"M Rubio-Valera","year":"2014","unstructured":"Rubio-Valera M, Chen TF, O'Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11:10967\u201390.","journal-title":"Int J Environ Res Public Health"},{"key":"1746_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/1471-2458-11-582","volume":"11","author":"CE Eades","year":"2011","unstructured":"Eades CE, Ferguson JS, O'Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582.","journal-title":"BMC Public Health"},{"key":"1746_CR4","doi-asserted-by":"publisher","first-page":"36S","DOI":"10.1177\/1077558709346277","volume":"66","author":"M Laurant","year":"2009","unstructured":"Laurant M, Harmsen M, Wollersheim H, Grol R, Faber M, Sibbald B. The impact of nonphysician clinicians: do they improve the quality and cost-effectiveness of health care services? Med Care Res Rev. 2009;66:36S\u201389S.","journal-title":"Med Care Res Rev"},{"key":"1746_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1592\/phco.23.15.1634.31952","volume":"23","author":"PR Finley","year":"2003","unstructured":"Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23:1634\u201344.","journal-title":"Pharmacotherapy"},{"key":"1746_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1743-8462-2-29","volume":"2","author":"S Bell","year":"2005","unstructured":"Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy. 2005;2:29.","journal-title":"Aust New Zealand Health Policy"},{"key":"1746_CR7","volume-title":"Changing Directions, Changing Lives: the Mental Health Strategy for Canada","author":"Anonymous","year":"2012","unstructured":"Anonymous. Changing Directions, Changing Lives: the Mental Health Strategy for Canada. Calgary: Mental Health Commission of Canada; 2012."},{"key":"1746_CR8","unstructured":"Kirby MJL, Keon WJ. The Standing Senate Committee on Social Affairs, Science and Technology. Out of the shadows at last: highlights and recommendations. Ottawa: Senate of Canada; 2006."},{"key":"1746_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/fampra\/cmh723","volume":"22","author":"M Wazaify","year":"2005","unstructured":"Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract. 2005;22:170\u20136.","journal-title":"Fam Pract"},{"key":"1746_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1715163512473062","volume":"146","author":"MR Law","year":"2013","unstructured":"Law MR, Heard D, Fisher J, Douillard J, Muzika G, Sketris IS. The geographic accessibility of pharmacies in Nova Scotia. Can Pharm J (Ott). 2013;146:39\u201346.","journal-title":"Can Pharm J (Ott)"},{"key":"1746_CR11","first-page":"55","volume":"145","author":"K Lynas","year":"2012","unstructured":"Lynas K. Professionals you can trust: pharmacists top the list again in Ipsos Reid survey. Can Pharm J (Ott). 2012;145:55.","journal-title":"Can Pharm J (Ott)."},{"key":"1746_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1176\/ps.2008.59.10.1155","volume":"59","author":"G Scheerder","year":"2008","unstructured":"Scheerder G, De Coster I, Van Audenhove C. Pharmacists\u2019 role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59:1155\u201360.","journal-title":"Psychiatr Serv"},{"key":"1746_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1176\/ps.2009.60.8.1123","volume":"60","author":"E Black","year":"2009","unstructured":"Black E, Murphy AL, Gardner DM. Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv. 2009;60:1123\u20137.","journal-title":"Psychiatr Serv"},{"key":"1746_CR14","doi-asserted-by":"crossref","unstructured":"Gardner DM, Murphy AL, Woodman AK, Connelly S. Community pharmacy services for antidepressant users. Int J Pharm Pract. 2001;9:217\u201324.","DOI":"10.1111\/j.2042-7174.2001.tb01052.x"},{"key":"1746_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1369-7625.2010.00643.x","volume":"14","author":"T Renberg","year":"2011","unstructured":"Renberg T, Wichman Tornqvist K, Kalvemark Sporrong S, Kettis Lindblad A, Tully MP. Pharmacy users\u2019 expectations of pharmacy encounters: a Q-methodological study. Health Expect. 2011;14:361\u201373.","journal-title":"Health Expect"},{"key":"1746_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/1715163513514170","volume":"147","author":"AL Murphy","year":"2014","unstructured":"Murphy AL, Szumilas M, Rowe D, Landry K, Martin-Misener RM, Kutcher S, Gardner DM. Pharmacy students\u2019 experience in community pharmacy mental health services provision. Can Pharm J. 2014;147:55\u201365.","journal-title":"Can Pharm J"},{"key":"1746_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.sapharm.2010.03.006","volume":"7","author":"K Crump","year":"2011","unstructured":"Crump K, Boo G, Liew FS, Olivier T, So C, Sung JY, Wong CH, Shaw J, Wheeler A. New Zealand community pharmacists\u2019 views of their roles in meeting medicine-related needs for people with mental illness. Res Social Adm Pharm. 2011;7:122\u201333.","journal-title":"Res Social Adm Pharm."},{"key":"1746_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10597-012-9580-4","volume":"50","author":"A Mey","year":"2014","unstructured":"Mey A, Fowler JL, Knox K, Shum DH, Fejzic J, Hattingh L, McConnell D, Wheeler A. Review of community pharmacy staff educational needs for supporting mental health consumers and carers. Community Ment Health J. 2014;50:59\u201367.","journal-title":"Community Ment Health J"},{"key":"1746_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/070674371405900802","volume":"59","author":"DM Gardner","year":"2014","unstructured":"Gardner DM. Competent psychopharmacology. Can J Psychiatr. 2014;59:406\u201311.","journal-title":"Can J Psychiatr"},{"key":"1746_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12913-016-1817-4","volume":"16","author":"AL Murphy","year":"2016","unstructured":"Murphy AL, Martin-Misener R, Kutcher SP, O\u2019Reilly C, Chen TF, Gardner DM. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness in community pharmacies. BMC Health Serv Res. 2016;16:569.","journal-title":"BMC Health Serv Res"},{"key":"1746_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13011-016-0050-9","volume":"11","author":"AL Murphy","year":"2016","unstructured":"Murphy AL, Phelan H, Haslam S, Martin-Misener R, Martin-Misener R, Kutcher S, Gardner DM. Community pharmacists\u2019 experiences in mental illness and addictions care: a qualitative study. Subst Abuse Treat Prev Policy. 2016;11:6.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1746_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1472-6963-12-229","volume":"12","author":"C Freeman","year":"2012","unstructured":"Freeman C, Cottrell WN, Kyle G, Williams I, Nissen L. Integrating a pharmacist into the general practice environment: opinions of pharmacist\u2019s, general practitioner\u2019s, health care consumer\u2019s, and practice manager\u2019s. BMC Health Serv Res. 2012;12:229.","journal-title":"BMC Health Serv Res"},{"key":"1746_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.sapharm.2014.07.002","volume":"11","author":"SR Carter","year":"2015","unstructured":"Carter SR, Moles R, White L, Chen TF. The impact of patients\u2019 perceptions of the listening skills of the pharmacist on their willingness to re-use home medicines reviews: a structural equation model. Res Social Adm Pharm. 2015;11:163\u201375.","journal-title":"Res Social Adm Pharm."},{"key":"1746_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.sapharm.2005.09.006","volume":"1","author":"LM Guirguis","year":"2005","unstructured":"Guirguis LM, Chewning BA. Role theory: literature review and implications for patient-pharmacist interactions. Res Social Adm Pharm. 2005;1:483\u2013507.","journal-title":"Res Social Adm Pharm"},{"key":"1746_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/1715163515596757","volume":"148","author":"AC Bishop","year":"2015","unstructured":"Bishop AC, Boyle TA, Morrison B, Barker JR, Zwicker B, Mahaffey T, Murphy A. Public perceptions of pharmacist expanded scope of practice services in Nova Scotia. Can Pharm J (Ott). 2015;148:274\u201383.","journal-title":"Can Pharm J (Ott)"},{"key":"1746_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.sapharm.2016.02.007","volume":"13","author":"TJ Schindel","year":"2017","unstructured":"Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA. Perceptions of pharmacists\u2019 roles in the era of expanding scopes of practice. Res Social Adm Pharm. 2017;13:148\u201361.","journal-title":"Res Social Adm Pharm."},{"key":"1746_CR27","unstructured":"Estimates of population, by age group and sex for July 1, Canada, provinces and territories. \n                    http:\/\/www5.statcan.gc.ca\/cansim\/a26?lang=eng&retrLang=eng&id=0510001&&pattern=&stByVal=1&p1=1&p2=37&tabMode=dataTable&csid=\n                    \n                  . Accessed 10 Dec 2016."},{"key":"1746_CR28","unstructured":"National Statistics: Provincial\/Territorial Statistics \u2013 Pharmacies. \n                    http:\/\/napra.ca\/national-statistics\n                    \n                  ."},{"key":"1746_CR29","volume-title":"Changing directions, changing lives: the mental health strategy for Canada","author":"Mental Health Commission of Canada","year":"2012","unstructured":"Mental Health Commission of Canada. Changing directions, changing lives: the mental health strategy for Canada. Calgary: Mental Health Commission of Canada; 2012."},{"key":"1746_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1503\/cmaj.121990","volume":"185","author":"C Tannenbaum","year":"2013","unstructured":"Tannenbaum C, Tsuyuki RT. The expanding scope of pharmacists\u2019 practice: implications for physicians. CMAJ. 2013;185:1228\u201332.","journal-title":"CMAJ"},{"key":"1746_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1715163513508914","volume":"146","author":"J Morrison","year":"2013","unstructured":"Morrison J. Expanded pharmacy practice: where are we, and where do we need to go? Can Pharm J (Ott). 2013;146:365\u20137.","journal-title":"Can Pharm J (Ott)."},{"key":"1746_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s11096-015-0171-7","volume":"37","author":"AL Murphy","year":"2015","unstructured":"Murphy AL, Martin-Misener R, Kutcher SP, Gardner DM. Pharmacists\u2019 performance in a telephone-based simulated patient study after a mental health capacity-building program. Int J Clin Pharm. 2015;37:1009\u201313.","journal-title":"Int J Clin Pharm"},{"key":"1746_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1752-4458-8-46","volume":"8","author":"AL Murphy","year":"2014","unstructured":"Murphy AL, Gardner DM, Kutcher SP, Martin-Misener R. A theory-informed approach to mental health care capacity building for pharmacists. Int J Ment Health Syst. 2014;8:46.","journal-title":"Int J Ment Health Syst"},{"key":"1746_CR34","unstructured":"The Bloom Program \n                    http:\/\/bloomprogram.ca\/\n                    \n                  . Accessed 07 May 2018."},{"key":"1746_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1748-5908-7-37","volume":"7","author":"J Cane","year":"2012","unstructured":"Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.","journal-title":"Implement Sci"},{"key":"1746_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.","journal-title":"Implement Sci"},{"key":"1746_CR37","unstructured":"More Than Meds. \n                    www.morethanmeds.com\n                    \n                  . Accessed 07 May 2018."},{"key":"1746_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1017\/S1121189X00002141","volume":"15","author":"R Mangalore","year":"2006","unstructured":"Mangalore R, Knapp M. Equity in mental health. Epidemiol Psichiatr Soc. 2006;15:260\u20136.","journal-title":"Epidemiol Psichiatr Soc"},{"key":"1746_CR39","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(07)61239-2","volume":"370","author":"S Saxena","year":"2007","unstructured":"Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007;370:878\u201389.","journal-title":"Lancet"},{"key":"1746_CR40","first-page":"SP25","volume":"5 Spec No","author":"LA Aday","year":"1999","unstructured":"Aday LA, Begley CE, Lairson DR, Slater CH, Richard AJ, Montoya IDA. Framework for assessing the effectiveness, efficiency, and equity of behavioral healthcare. Am J Manag Care. 1999;5 Spec No:SP25\u201344.","journal-title":"Am J Manag Care"},{"key":"1746_CR41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2146\/ajhp130484","volume":"71","author":"A Fanous","year":"2014","unstructured":"Fanous A, Kier K, Rush MJ, Terrell S. Impact of a 12-week, pharmacist-directed walking program in an established employee preventive care clinic. Am J Health Syst Pharm. 2014;71:1219\u201325.","journal-title":"Am J Health Syst Pharm"},{"key":"1746_CR42","doi-asserted-by":"publisher","first-page":"e009828","DOI":"10.1136\/bmjopen-2015-009828","volume":"6","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Todd A, O'Malley C, Moore HJ, Husband AK, Bambra C, Kasim A, Sniehotta FF, Steed L, Smith S, Nield L, Summerbell CD. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6:e009828.","journal-title":"BMJ Open"},{"key":"1746_CR43","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.sapharm.2016.06.015","volume":"13","author":"JM Lonie","year":"2017","unstructured":"Lonie JM, Austin Z, Nguyen R, Gill I, Tsingos-Lucas C. Pharmacist-based health coaching: a new model of pharmacist-patient care. Res Social Adm Pharm. 2017;13:644\u201352.","journal-title":"Res Social Adm Pharm."},{"key":"1746_CR44","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1186\/1471-2458-14-1139","volume":"14","author":"S Brown","year":"2014","unstructured":"Brown S, Henderson E, Sullivan C. The feasibility and acceptability of the provision of alcohol screening and brief advice in pharmacies for women accessing emergency contraception: an evaluation study. BMC Public Health. 2014;14:1139.","journal-title":"BMC Public Health"},{"key":"1746_CR45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1331\/154434505774909661","volume":"45","author":"TL Lenz","year":"2005","unstructured":"Lenz TL, Stading JA. Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health professionals. J Am Pharm Assoc (2003). 2005;45:709\u201313.","journal-title":"J Am Pharm Assoc (2003)"},{"key":"1746_CR46","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1331\/108658002763316950","volume":"42","author":"RL Couchenour","year":"2002","unstructured":"Couchenour RL, Carson DS, Segal AR. Patients\u2019 views of pharmacists as providers of smoking cessation services. J Am Pharm Assoc (Wash). 2002;42:510\u20132.","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"1746_CR47","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1465-3362.2010.00234.x","volume":"29","author":"R Dhital","year":"2010","unstructured":"Dhital R, Whittlesea CM, Norman IJ, Milligan P. Community pharmacy service users\u2019 views and perceptions of alcohol screening and brief intervention. Drug Alcohol Rev. 2010;29:596\u2013602.","journal-title":"Drug Alcohol Rev"},{"key":"1746_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.puhe.2013.11.001","volume":"128","author":"J Krska","year":"2014","unstructured":"Krska J, Mackridge AJ. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service. Public Health. 2014;128:309\u201316.","journal-title":"Public Health"},{"key":"1746_CR49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2147\/PPA.S48486","volume":"7","author":"WW Chong","year":"2013","unstructured":"Chong WW, Aslani P, Chen TF. Adherence to antidepressant medications: an evaluation of community pharmacists\u2019 counseling practices. Patient Prefer Adherence. 2013;7:813\u201325.","journal-title":"Patient Prefer Adherence"},{"key":"1746_CR50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/0020764013503149","volume":"60","author":"K Knox","year":"2014","unstructured":"Knox K, Fejzic J, Mey A, Fowler JL, Kelly F, McConnell D, Hattingh L, Wheeler AJ. Mental health consumer and caregiver perceptions of stigma in Australian community pharmacies. Int J Soc Psychiatry. 2014;60:533\u201343.","journal-title":"Int J Soc Psychiatry"},{"key":"1746_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.sapharm.2014.10.006","volume":"11","author":"P Sakharkar","year":"2015","unstructured":"Sakharkar P, Bounthavong M, Hirsch JD, Morello CM, Chen TC, Law AV. Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services. Res Social Adm Pharm. 2015;11:487\u201398.","journal-title":"Res Social Adm Pharm."},{"key":"1746_CR52","first-page":"77","volume":"6","author":"ML Fleming","year":"2015","unstructured":"Fleming ML, Ferries EA, Hatfield MD, Atreja N, Yucel A, Rane PP, Sharma M, Wang X. Patients\u2019 beliefs regarding counseling provided by community pharmacists: an application of the theory of planned behaviour. JPHSR. 2015;6:77\u20139.","journal-title":"JPHSR"},{"key":"1746_CR53","doi-asserted-by":"publisher","first-page":"E208","DOI":"10.9778\/cmajo.20130076","volume":"2","author":"S Alessi-Severini","year":"2014","unstructured":"Alessi-Severini S, Bolton JM, Enns MW, Dahl M, Collins DM, Chateau D, Sareen J. Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open. 2014;2:E208\u201316.","journal-title":"CMAJ Open"},{"key":"1746_CR54","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1176\/appi.ps.201500380","volume":"67","author":"S Alessi-Severini","year":"2016","unstructured":"Alessi-Severini S, Bolton JM, Enns MW, Dahl ME, Chateau D, Collins DM, Sareen J. Sustained use of benzodiazepines and escalation to high doses in a Canadian population. Psychiatr Serv. 2016;67:1012\u20138.","journal-title":"Psychiatr Serv"},{"key":"1746_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/S0714980816000702","volume":"36","author":"C Tannenbaum","year":"2017","unstructured":"Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J. An ecological approach to reducing potentially inappropriate medication use: Canadian Deprescribing network. Can J Aging. 2017;36:97\u2013107.","journal-title":"Can J Aging"},{"key":"1746_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12877-017-0432-5","volume":"17","author":"P Martin","year":"2017","unstructured":"Martin P, Tannenbaum C. Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment. BMC Geriatr. 2017;17:37.","journal-title":"BMC Geriatr"},{"key":"1746_CR57","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174:890\u20138.","journal-title":"JAMA Intern Med"},{"key":"1746_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/08897077.2017.1290011","volume":"38","author":"D Pardo","year":"2017","unstructured":"Pardo D, Miller L, Chiulli D. Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a veteran population. Subst Abus. 2017;38:157\u201360.","journal-title":"Subst Abus"},{"key":"1746_CR59","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4088\/JCP.v66n0503","volume":"66","author":"KM Saari","year":"2005","unstructured":"Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Jarvelin MR, Lauren LH, Savolainen MJ, Koponen HJ. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the northern Finland 1966 birth cohort study. J Clin Psychiatry. 2005;66:559\u201363.","journal-title":"J Clin Psychiatry"},{"key":"1746_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/070674370505001003","volume":"50","author":"JM Starkes","year":"2005","unstructured":"Starkes JM, Poulin CC, Kisely SR. Unmet need for the treatment of depression in Atlantic Canada. Can J Psychiatr. 2005;50:580\u201390.","journal-title":"Can J Psychiatr"},{"key":"1746_CR61","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/070674370505001007","volume":"50","author":"HM Vasiliadis","year":"2005","unstructured":"Vasiliadis HM, Lesage A, Adair C, Boyer R. Service use for mental health reasons: cross-provincial differences in rates, determinants, and equity of access. Can J Psychiatr. 2005;50:614\u20139.","journal-title":"Can J Psychiatr"},{"key":"1746_CR62","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(09)61942-5","volume":"374","author":"M De Hert","year":"2009","unstructured":"De Hert M, Peuskens J, van Winkel R. Mortality in patients with schizophrenia. Lancet. 2009;374:1591.","journal-title":"Lancet"},{"key":"1746_CR63","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1192\/bjp.bp.110.081695","volume":"199","author":"S Kisely","year":"2011","unstructured":"Kisely S, Quek LH, Pais J, Lalloo R, Johnson NW, Lawrence D. Advanced dental disease in people with severe mental illness: systematic review and meta-analysis. Br J Psychiatry. 2011;199:187\u201393.","journal-title":"Br J Psychiatry"},{"key":"1746_CR64","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/070674371005501202","volume":"55","author":"D Lawrence","year":"2010","unstructured":"Lawrence D, Kisely S, Pais J. The epidemiology of excess mortality in people with mental illness. Can J Psychiatr. 2010;55:752\u201360.","journal-title":"Can J Psychiatr"},{"key":"1746_CR65","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1192\/bjp.bp.109.067082","volume":"195","author":"S Kisely","year":"2009","unstructured":"Kisely S, Campbell LA, Wang Y. Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br J Psychiatry. 2009;195:545\u201350.","journal-title":"Br J Psychiatry"},{"key":"1746_CR66","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1177\/070674370805301107","volume":"53","author":"S Kisely","year":"2008","unstructured":"Kisely S, Sadek J, MacKenzie A, Lawrence D, Campbell LA. Excess cancer mortality in psychiatric patients. Can J Psychiatr. 2008;53:753\u201361.","journal-title":"Can J Psychiatr"},{"key":"1746_CR67","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1503\/cmaj.060482","volume":"176","author":"S Kisely","year":"2007","unstructured":"Kisely S, Smith M, Lawrence D, Cox M, Campbell LA, Maaten S. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ. 2007;176:779\u201384.","journal-title":"CMAJ"},{"key":"1746_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/01.psy.0000149280.88430.7c","volume":"67","author":"S Kisely","year":"2005","unstructured":"Kisely S, Simon G. An international study of the effect of physical ill health on psychiatric recovery in primary care. Psychosom Med. 2005;67:116\u201322.","journal-title":"Psychosom Med"},{"key":"1746_CR69","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1345\/aph.1K617","volume":"42","author":"AS Roberts","year":"2008","unstructured":"Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42:861\u20138.","journal-title":"Ann Pharmacother"},{"key":"1746_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.sapharm.2016.01.005","volume":"13","author":"MA Smith","year":"2017","unstructured":"Smith MA, Spiggle S, McConnell B. Strategies for community-based medication management services in value-based health plans. Res Social Adm Pharm. 2017;13:48\u201362.","journal-title":"Res Social Adm Pharm"},{"key":"1746_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.sapharm.2013.03.003","volume":"10","author":"KM Wells","year":"2014","unstructured":"Wells KM, Thornley T, Boyd MJ, Boardman HF. Views and Experiences of community pharmacists and superintendent pharmacists regarding the new medicine Service in England prior to implementation. Res Social Adm Pharm. 2014;10:58\u201371.","journal-title":"Res Social Adm Pharm"},{"key":"1746_CR72","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1345\/aph.1E456","volume":"39","author":"EJ Jones","year":"2005","unstructured":"Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39:1527\u201333.","journal-title":"Ann Pharmacother"},{"key":"1746_CR73","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bcp.12140","volume":"77","author":"E Hatah","year":"2014","unstructured":"Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77:102\u201315.","journal-title":"Br J Clin Pharmacol"},{"key":"1746_CR74","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3821\/1913-701X(2008)141[102:ASRORS]2.0.CO;2","volume":"141","author":"P Chan","year":"2017","unstructured":"Chan P, Grindrod KA, Bougher D, Pasutto FM, Wilgosh C, Eberhart G, Tsuyuki RA. Systematic review of remuneration Systems for Clinical Pharmacy Care Services. Can Pharm J. 2017;141:102\u201312.","journal-title":"Can Pharm J"},{"key":"1746_CR75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1715163514536678","volume":"147","author":"SK Houle","year":"2014","unstructured":"Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147:209\u201332.","journal-title":"Can Pharm J (Ott)"},{"key":"1746_CR76","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00005650-198103000-00009","volume":"19","author":"DP Lipson","year":"1981","unstructured":"Lipson DP, Yesalis CE 3rd, Kohout FJ, Norwood GJ. Capitation payment for medicaid pharmacy services: impact on non-medicaid prescriptions. Med Care. 1981;19:342\u201353.","journal-title":"Med Care"},{"key":"1746_CR77","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/106002808101500904","volume":"15","author":"GJ Norwood","year":"1981","unstructured":"Norwood GJ, Helling DK, Burmeister LF, Jones ME, Yesalis CE 3rd, Fisher WP, Lipson DP. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: II. Therapeutic category analysis, over-the-counter drug usage, and drug interactions. Drug Intell Clin Pharm. 1981;15:656\u201364.","journal-title":"Drug Intell Clin Pharm"},{"key":"1746_CR78","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00005650-198408000-00005","volume":"22","author":"CE Yesalis 3rd","year":"1984","unstructured":"Yesalis CE 3rd, Lipson DP, Norwood GJ, Helling DK, Burmeister LF, Jones ME, Fisher WP. Capitation payment for pharmacy services. I Impact on drug use and pharmacist dispensing behavior. Med Care. 1984;22:737\u201345.","journal-title":"Med Care"},{"key":"1746_CR79","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/00005650-198408000-00006","volume":"22","author":"CE Yesalis 3rd","year":"1984","unstructured":"Yesalis CE 3rd, Norwood GJ, Helling DK, Lipson DP, Mahrenholz RJ, Burmeister LF, Jones ME, Fisher WP. Capitation payment for pharmacy services. II Impact on costs. Med Care. 1984;22:746\u201354.","journal-title":"Med Care"},{"key":"1746_CR80","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.socscimed.2014.11.001","volume":"124","author":"D Rudoler","year":"2015","unstructured":"Rudoler D, Laporte A, Barnsley J, Glazier RH, Deber RB. Paying for primary care: a cross-sectional analysis of cost and morbidity distributions across primary care payment models in Ontario Canada. Soc Sci Med. 2015;124:18\u201328.","journal-title":"Soc Sci Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1746-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-018-1746-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1746-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T19:08:30Z","timestamp":1560452910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-018-1746-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,14]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s12888-018-1746-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,14]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ALM and DMG are academic faculty at Dalhousie University, Halifax, Nova Scotia, Canada. LMJ is an independent program evaluator in Halifax, NS. Our research program is focused on designing, developing, and implementing interventions for community pharmacists caring for people with lived experience of mental illness and addictions in primary health care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Dalhousie University Research Ethics Board reviewed the demonstration project proposal and ethics submission and determined that it constituted program evaluation. A formal ethics review was therefore not provided. A privacy impact assessment was completed and approved by the government of Nova Scotia in accordance with provincial privacy legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"192"}}